EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance

Annemarie M Wensing iD, Charlotte Charpentier, Vincent Calvez iD, Francesca Ceccherini-Silberstein, Huldrych F Günthard iD, Donna M Jacobsen, Roger Paredes iD, Robert W Shafer, Douglas D Richman iD

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciaf161 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Annemarie M Wensing und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Health and Bio-Ethics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Nethe…. Hauptthemen laut MEDLINE: Proviruses, HIV Infections, Drug Resistance, Viral, DNA, Viral. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Society, IAS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The improved efficacy and tolerability of newer antiretroviral drugs, as well as the introduction of long-acting regimens, have prompted more frequent therapy switches in individuals on suppressive antiretroviral therapy (ART). For these individuals, the assessment of HIV drug resistance using DNA from peripheral blood lymphocytes has become increasingly popular. However, compared with HIV RNA-based analyses, implementation of HIV DNA testing as an alternative approach in clinical care requires new documented quality-assessment procedures and clinical validation. Furthermore, the use of HIV DNA to assess drug resistance has some distinct technical and biologic challenges that are relevant to the clinical management of people with HIV. This Viewpoint article addresses the issues relevant to clinical virologists and treating physicians for the interpretation of drug-resistance testing or subtype assessment based on DNA analysis, when HIV RNA genotypic assessment is not possible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProvirusesHIV InfectionsDrug Resistance, ViralDNA, ViralAnti-HIV AgentsHIV-1HIVHumans

Stichwörter der Autor:innen

HIV-1antiretroviral drugsdrug resistancelong-acting drug regimenproviral DNA testing

Substanzen

DNA, ViralAnti-HIV Agents

Autor:innen und Institutionen

  • Department of Global Health and Bio-Ethics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Department of Virology, Paris Cité University and Bichat-Claude Bernard Hospital, Paris, France.
  • Department of Virology, Sorbonne Université School of Medicine, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Laboratoire de Virologie…
  • Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

ORCID-Profile: Annemarie M Wensing, Vincent Calvez, Huldrych F Günthard, Roger Paredes, Douglas D Richman

Förderung

  • NIAID NIH HHS
  • Society
  • IAS

Zitieren

APA

Wensing, A. M., Charpentier, C., Calvez, V., Ceccherini-Silberstein, F., Günthard, H. F., Jacobsen, D. M., Paredes, R., Shafer, R. W., & Richman, D. D. (2025). Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf161

Vancouver

Wensing AM, Charpentier C, Calvez V, Ceccherini-Silberstein F, Günthard HF, Jacobsen DM, et al. Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf161

BibTeX
@article{Wensing2025,
  author = {Wensing, Annemarie M and Charpentier, Charlotte and Calvez, Vincent and Ceccherini-Silberstein, Francesca and Günthard, Huldrych F and Jacobsen, Donna M and Paredes, Roger and Shafer, Robert W and Richman, Douglas D},
  title = {Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciaf161}
}
Kostenlos starten →